A Novel Polymorphism (rs35612982) in <b><i>CDKAL1</i></b> Is a Risk Factor of Type 2 Diabetes: A Case-Control StudyYanni Tian, Wei Cui, Xin He et al.|Kidney & Blood Pressure Research|2019Cited by 19
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trialFeng‐Hua Wang, Rui‐Hua Xu, Guanghai Dai et al.|Chinese Journal of Cancer Research|2021Cited by 11
PDX1 and MC4R genetic polymorphisms are associated with type 2 diabetes mellitus risk in the Chinese Han populationNing Wang, Wei Cui, Rui Tong et al.|BMC Medical Genomics|2021Cited by 8
Relationship Between KCNQ1 Polymorphism and Type 2 Diabetes Risk in Northwestern ChinaJing Xu, Wei Cui, Wei Zhang et al.|Pharmacogenomics and Personalized Medicine|2021Cited by 4
Relationship between KCNQ1 gene polymorphisms and type 2 diabetes in the population of northwestern China and a meta-AnalysisJing Xu, Bingyin Shi, Wei Zhang et al.|Unknown|2019Cited by 0